Central Nervous System/Leptomeningeal Neoplasms
1 clinical trials · Condition
◉ Watch Central Nervous System/Leptomeningeal Neoplasms
| Record | Firm | Date |
|---|---|---|
| 131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults (NCT05064306) | Memorial Sloan Kettering Cancer Center |
Track Central Nervous System/Leptomeningeal Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.